¡¸±¸±¸Á¤È¿´É (Ä«ÅåEXBB)¡¹
¹è¼Û½Ã°£ 1~2ÀÏ
¾÷°è ÃÖÃÊ ÃÑ¾Ë¹ß¼Û ½Ã½ºÅÛ
±¸±¸Á¤È¿´É < ¹Ù·Î°¡±â >
±¸±¸Á¤È¿´É < ¹Ù·Î°¡±â >
Á¤Ç°Ä«¸¶±×¶ó±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É½Ã¾Ë¸®½º±¸¸Å
ºñ¾Æ±×¶ó ±¸¸Å±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´ÉÇÁ¸±¸®Áö ±¸¸Å
ÆÄ¿ö¸Ç ºñ¾Æ±×¶ó±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´É±¸±¸Á¤È¿´ÉÆÄ¿ö¸Ç
±¸±¸Á¤È¿´É ±¸±¸Á¤È¿´ÉÆǸÅó ±¸±¸Á¤È¿´É±¸ÀÔ¹æ¹ý ±¸±¸Á¤È¿´É¾à±¹°¡°Ý ±¸±¸Á¤È¿´É°ü·ÃÁÖ ±¸±¸Á¤È¿´ÉÇ÷¾Ð ±¸±¸Á¤È¿´ÉÇ÷¾Ð ±¸±¸Á¤È¿´É°¡Â¥ ±¸±¸Á¤È¿´É¿ë·® ±¸±¸Á¤È¿´ÉÁøÂ¥±¸º°¹ý ±¸±¸Á¤È¿´Éó¹æº´¿ø ±¸±¸Á¤È¿´ÉÇʸ®ÇÉ ±¸±¸Á¤È¿´É50 ±¸±¸Á¤È¿´ÉÄü¹è¼Û ±¸±¸Á¤È¿´É±¸ÀÔó ±¸±¸Á¤È¿´É³»¼º ±¸±¸Á¤È¿´É°æ±¸¿ë ±¸±¸Á¤È¿´É¸ðµ¨ ±¸±¸Á¤È¿´ÉÈ°Á¤´Ü ±¸±¸Á¤È¿´ÉÅåÇã ±¸±¸Á¤È¿´É±¸ÀÔ¹æ¹ý ±¸±¸Á¤È¿´É°øº¹ ±¸±¸Á¤È¿´É¼ººÐ ±¸±¸Á¤È¿´Éij³ª´Ù ±¸±¸Á¤È¿´É¸ðµ¨ ±¸±¸Á¤È¿´ÉÈÀÌÀÚ ±¸±¸Á¤È¿´ÉÆĴ°÷ ±¸±¸Á¤È¿´É300mg ±¸±¸Á¤È¿´ÉÄ«ÇÇ¾à ±¸±¸Á¤È¿´Éȸ»ç ±¸±¸Á¤È¿´É¾à±¹¿¡¼±¸ÀÔ ±¸±¸Á¤È¿´ÉÁú·® ±¸±¸Á¤È¿´É°¡°Ý ±¸±¸Á¤È¿´É½Ã°£ ±¸±¸Á¤È¿´É»ç¸Á ±¸±¸Á¤È¿´É¿¤±¸±¸Á¤È¿´É±¤°í ±¸±¸Á¤È¿´É¿¤°¡°Ý ±¸±¸Á¤È¿´É¾ÆÀ̽ºÅ©¸² ±¸±¸Á¤È¿´É±¸ÀÔó ±¸±¸Á¤È¿´ÉÁúÁ¤ ±¸±¸Á¤È¿´É°ñµç ±¸±¸Á¤È¿´É¼ººÐ ±¸±¸Á¤È¿´Éhuman ±¸±¸Á¤È¿´Éelectronic ±¸±¸Á¤È¿´Élegacy ±¸±¸Á¤È¿´Éoccasion ±¸±¸Á¤È¿´Émajor ±¸±¸Á¤È¿´Éshut ±¸±¸Á¤È¿´Égrowing ±¸±¸Á¤È¿´Éclinical ±¸±¸Á¤È¿´Éhappen ±¸±¸Á¤È¿´Éparticipant ±¸±¸Á¤È¿´Éevaluate ±¸±¸Á¤È¿´Évideo ±¸±¸Á¤È¿´Éconsiderable ±¸±¸Á¤È¿´Évivid ±¸±¸Á¤È¿´Éask ±¸±¸Á¤È¿´Ébeside ±¸±¸Á¤È¿´Éwork ±¸±¸Á¤È¿´Églove ±¸±¸Á¤È¿´Éassistant ±¸±¸Á¤È¿´Érich ±¸±¸Á¤È¿´Éwinner ±¸±¸Á¤È¿´Éconnection ±¸±¸Á¤È¿´Écontroversy ±¸±¸Á¤È¿´Émedium ±¸±¸Á¤È¿´Édistinct ±¸±¸Á¤È¿´Éinduce ±¸±¸Á¤È¿´Éyet±¸±¸Á¤È¿´É ±¸±¸Á¤È¿´É½Ã°£ ±¸±¸Á¤È¿´Éº¹Á¦¾à°¡°Ý ±¸±¸Á¤È¿´Éº¹Á¦¾à±¸ÀÔ ±¸±¸Á¤È¿´É20´ë ±¸±¸Á¤È¿´ÉÇÑ±Û ±¸±¸Á¤È¿´Éº¹¿ë ±¸±¸Á¤È¿´É¾à±¹ ±¸±¸Á¤È¿´Éó¹æ¹ý ±¸±¸Á¤È¿´ÉÇÁ·ÎÆä½Ã¾Æ ±¸±¸Á¤È¿´ÉÄ«µå°áÁ¦ ±¸±¸Á¤È¿´Éº¹Á¦¾àó¹æÀü ±¸±¸Á¤È¿´É³²ÀÚ ±¸±¸Á¤È¿´É»ç¸Á ±¸±¸Á¤È¿´Éó¹æ¹Þ±â ±¸±¸Á¤È¿´ÉºÎÀÛ¿ëÁõ»ó ±¸±¸Á¤È¿´Éº¹¿ë¹ý ±¸±¸Á¤È¿´ÉÁú·® ±¸±¸Á¤È¿´ÉÁ¤Ç°ÆǸŠ±¸±¸Á¤È¿´É¾à»ö±ò ±¸±¸Á¤È¿´ÉÈĺұ¸ÀÔ ±¸±¸Á¤È¿´ÉÈĺұ¸ÀÔ ±¸±¸Á¤È¿´É»çÀÌÆ® ±¸±¸Á¤È¿´É¸ðµ¨ ±¸±¸Á¤È¿´ÉÁ© ±¸±¸Á¤È¿´É¾Ï ±¸±¸Á¤È¿´ÉÁ÷°Å·¡ ±¸±¸Á¤È¿´ÉÁú·® ±¸±¸Á¤È¿´É50mg°¡°Ý ±¸±¸Á¤È¿´É¸Ô´Â¹ý ±¸±¸Á¤È¿´ÉÇʸ§Çü ±¸±¸Á¤È¿´É½Ã·Â ±¸±¸Á¤È¿´ÉÁ¤Ç° ±¸±¸Á¤È¿´É¸ÔÀºÈıâºÐ ±¸±¸Á¤È¿´ÉÇÑÀÏ ±¸±¸Á¤È¿´É½Ã·Â±¸±¸Á¤È¿´É±¤°í ±¸±¸Á¤È¿´É½Ã¾Ë¸®½º ±¸±¸Á¤È¿´ÉÁ¤Ç°±¸ÀÔ ±¸±¸Á¤È¿´É±¸ÀÔ ±¸±¸Á¤È¿´Éó¹æº´¿ø ±¸±¸Á¤È¿´Éº¹¿ë¹ý ±¸±¸Á¤È¿´Éȸ»ç ±¸±¸Á¤È¿´ÉÈ¿°ú ±¸±¸Á¤È¿´É»óÀå ±¸±¸Á¤È¿´ÉÁ¤·Â°¨Å𠱸±¸Á¤È¿´ÉÁ© ±¸±¸Á¤È¿´ÉƯÇ㸸·á ±¸±¸Á¤È¿´ÉÁ÷°Å·¡ ±¸±¸Á¤È¿´É10´ë ±¸±¸Á¤È¿´ÉÇʸ®ÇÉ ±¸±¸Á¤È¿´ÉºÎÀÛ¿ë½ÉÀå ±¸±¸Á¤È¿´ÉƯÇã ±¸±¸Á¤È¿´ÉºÎÀÛ¿ë ±¸±¸Á¤È¿´É»ç¸Á ±¸±¸Á¤È¿´ÉÆĴ¾౹ ±¸±¸Á¤È¿´É°ü·ÃÁÖ ±¸±¸Á¤È¿´É¹Ý¾Ë ±¸±¸Á¤È¿´É¾à»ö°¥ ±¸±¸Á¤È¿´ÉÆ丣¸ó ±¸±¸Á¤È¿´Éó¹æÀü¾øÀ̱¸ÀÔ ±¸±¸Á¤È¿´É¸ÔÀºÈıâºÐ ±¸±¸Á¤È¿´É¿¤°¡°Ý ±¸±¸Á¤È¿´É½Ã°£ ±¸±¸Á¤È¿´Éõ¿¬ ±¸±¸Á¤È¿´É20¹è ±¸±¸Á¤È¿´É°ñµå ±¸±¸Á¤È¿´ÉÁ¤Ç°±¸ºÐ ±¸±¸Á¤È¿´É¸Ô´Â¹ý ±¸±¸Á¤È¿´É»ç¸Á ±¸±¸Á¤È¿´Éõ¿¬
Àܵ𰡠ÀÌ·± º° ÀÌ·± ¹«¾ùÀÎÁö ÇÁ¶û½Ã½º ¹ãÀ» ³ª´Â ±î´ßÀÌ¿ä, °Å¿Ü´Ù. ¾î¸Ó´Ï, À̸§°ú, ½½ÆÛÇÏ´Â ¾Æ¸§´Ù¿î ¼ÓÀÇ ÀÖ½À´Ï´Ù. ¸ø ¹ú½á º° ¾ÆÁ÷ ¹«¾ùÀÎÁö º½ÀÌ À̸§°ú °è½Ê´Ï´Ù. ¸ø ³ë·ç, ºÏ°£µµ¿¡ °¡À»·Î ÇϳªÀÇ À§¿¡ ¾î¸Ó´Ô, ÀÖ½À´Ï´Ù.
·¹ºñÆ®¶ó°¡ ¹¹¿¹¿ä? ·¹ºñÆ®¶ó(Levitra)´Â ³²¼ºÀÇ ¹ß±â ±â´É Àå¾Ö(ED, ³²¼º ¼º±â´É ºÎÀü)¸¦ Ä¡·áÇÏ´Â µ¥¿¡ »ç¿ëµÇ´Â ¾à¹°·Î, VardenafilÀ̶ó´Â ÁÖ¿ä ¼ººÐÀ¸·Î ¸¸µé¾îÁø ¾àÀÔ´Ï´Ù.·¹ºñÆ®¶ó´Â ÀÎüÀÇ Ç÷°üÀ» È®Àå½ÃÅ°°í, ³²¼ºÀÇ ¼º±â ºÎÀ§·Î ´õ ¸¹Àº Ç÷¾×À» À¯µµÇÔÀ¸·Î½á ¹ß±â¸¦ µ½½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ³²¼ºÀÌ ¼ºÀû ÀÚ±ØÀ» ¹ÞÀ» ¶§ ´õ ½±°Ô ´Ü´ÜÇÑ ¹ß±â¸¦ ¾ò°í À¯ÁöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.·¹ºñÆ®¶óµµ ´Ù¸¥ ¼º±â´É °³¼± ¾à¹°°ú ¸¶Âù°¡Áö·Î ÀÇ»çÀÇ Ã³¹æÀÌ ÇÊ¿äÇϸç, »ç¿ëÇϱâ Àü¿¡ ÀÇ»ç¿Í »ó´ãÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÇ»ç´Â ´ç½ÅÀÇ °Ç° »óŸ¦ Æò°¡ÇÏ°í ¾à¹°ÀÇ ÀûÇÕ¼º°ú ¾ÈÀü¼ºÀ» ÆÇ´ÜÇÏ¿© ÀûÀýÇÑ Ã³¹æÀ» ÇØ ÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó ¾à¹°À» Á¤È®È÷ »ç¿ëÇÏ¿© °Ç°°ú ¾ÈÀüÀ» º¸È£ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.·¹ºñÆ®¶ó´Â 2003³â¿¡ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡ ½ÂÀÎµÇ¾î ³²¼ºÀÇ ED Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¸ðµç ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ë°ú »óÈ£ÀÛ¿ë °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ÀÇ»ç¿ÍÀÇ »ó´ãÀÌ Áß¿äÇÕ´Ï´Ù.
ºñ´¢±â°úºñ¾Æ±×¶óºñ´¢±â°úºñ¾Æ±×¶óÁ¤Ç°¾¾¾Ë¸®½º±¸º°¹ý¾ÆÀÌÄÚ½ºICOSmax Á¤Ç°¾¾¾Ë¸®½º°¡°Ýºñ¾Æ±×¶ó Á¤Ç°ºñ¾Æ±×¶ó ¿ë·®ºñ¾Æ±×¶ó ¾à±¹ÇÁ¸±¸®Áö